Pete Meyers
Director/Board Member at IMMUTEP LIMITED
Net worth: 914 277 $ as of 29/04/2024
Pete Meyers active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IMMUTEP LIMITED | Director/Board Member | 11/02/2014 | - |
| Independent Dir/Board Member | 11/02/2014 | - | |
| Thomas M Brennan Memorial Foundation, Inc. | Chairman | 31/08/2001 | - |
| President | 31/08/2001 | - | |
| East End Hospice, Inc. | Director/Board Member | - | - |
Slayback Pharma LLC
 Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Director of Finance/CFO | - | - |
Hospice, Inc. (Iowa)
 Hospice, Inc. (Iowa) Medical/Nursing ServicesHealth Services Hospice, Inc. is a private company based in Ottumwa, IA and has subsidiaries in United States. The company provides hospice care. | Director/Board Member | - | - |
Career history of Pete Meyers
Former positions of Pete Meyers
| Companies | Position | Start | End |
|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. | Director of Finance/CFO | 14/05/2017 | 28/10/2020 |
| MOTIF BIO PLC | Comptroller/Controller/Auditor | 30/04/2016 | 16/01/2017 |
| Director of Finance/CFO | 30/04/2016 | 16/01/2017 | |
Motif BioSciences, Inc.
 Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Director of Finance/CFO | 30/04/2016 | 31/12/2016 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Director of Finance/CFO | 18/08/2013 | 29/02/2016 |
| Treasurer | 31/08/2013 | 29/02/2016 | |
| ░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Pete Meyers
| Boston College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistics
International
| United States | 11 |
| Australia | 2 |
| United Kingdom | 2 |
Operational
| Director of Finance/CFO | 5 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| IMMUTEP LIMITED | Health Technology |
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
| Dillon, Read & Co., Inc. | Finance |
| Thomas M Brennan Memorial Foundation, Inc. | |
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Health Technology |
| East End Hospice, Inc. | |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Health Technology |
Hospice, Inc. (Iowa)
Hospice, Inc. (Iowa) Medical/Nursing ServicesHealth Services Hospice, Inc. is a private company based in Ottumwa, IA and has subsidiaries in United States. The company provides hospice care. | Health Services |
- Stock Market
- Insiders
- Pete Meyers
- Experience
